Table 1.

Overview of the recommendations on how to prioritize and adapt treatment for breast cancer patients during the COVID-19 pandemic

Recommendations	Source
Neo-adjuvant chemotherapy should only be used for inoperable patients	Associations of breast surgery [4]
Neo-adjuvant endocrine therapy can be used to postpone surgery	Association of breast surgery [4], European Association of Medical Oncology (ESMO) [5], COVID-19 pandemic breast cancer consortium [6], Dutch Society of Medical Oncology (NVMO), Dutch Society of Surgical Oncology (NVCO) [7]
Lowest priority should be given to the surgery of low-grade DCIS	European Association of Medical Oncology (ESMO) [5], COVID-19 pandemic breast cancer consortium [6], Dutch Society of Medical Oncology (NVMO), Dutch Society of Surgical Oncology (NVCO) [7]
Immediate breast reconstructions should be avoided	Associations of Breast Surgery [4]
Immediate breast reconstruction with autologous tissue has the lowest priority	COVID-19 pandemic breast cancer consortium [6], American Society of Plastic Surgeons [8]
Chemotherapy can be used after radiotherapy in carefully selected patients	COVID-19 pandemic breast cancer consortium [6]